5 Item 1A. Risk Factors 31 Item 1B. Unresolved Staff Comments 87 Item 1C. Cybersecurity 87 Item 2. Properties 87 Item 3. Legal Proceedings 88 Item 4. Mine Safety Disclosures 88 Part II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 89 Item 6. [Reserved] 89 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 90 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 100 Item 8...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001193125-26-083012 | EDGAR | 87K words |
| 2025-02-28 | 2024-12-31 | 0000950170-25-030102 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0000950170-24-027933 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006998 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0000950170-22-004111 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012501 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010493 | EDGAR | — |
| 2019-03-08 | 2018-12-31 | 0001564590-19-006997 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001193125-18-102077 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001193125-17-104228 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-266989 | EDGAR | 59K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104971 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071602 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123248 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089238 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052056 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000950170-23-058829 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037934 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017827 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024434 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0000950170-22-015115 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0000950170-22-007890 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001193125-26-137984 | EDGAR | 1K words |
| 2026-03-17 | 0001193125-26-109511 | EDGAR | — |
| 2025-12-31 | 0001193125-25-338394 | EDGAR | — |
| 2025-12-16 | 0001193125-25-319638 | EDGAR | — |
| 2025-11-13 | 0001193125-25-278804 | EDGAR | — |
| 2025-10-28 | 0001193125-25-252200 | EDGAR | — |
| 2025-08-19 | 0000950170-25-109932 | EDGAR | — |
| 2025-07-17 | 0001213900-25-064869 | EDGAR | — |
| 2025-06-26 | 0001213900-25-058035 | EDGAR | — |
| 2025-06-17 | 0001213900-25-054949 | EDGAR | — |
264 total filings indexed. 232 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001341235 |
| Ticker | ALDX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aldeyra.com |
| Listed | 2014-05-02 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report